Salvatore Cuzzocrea Selected Research

Pleurisy (Pleuritis)

1/2024	Retraction notice to "Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody" [Clin. Immunol. 113/1 (2004) 64-73].
1/2017	Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy.
5/2014	Costunolide and Dehydrocostuslactone, two natural sesquiterpene lactones, ameliorate the inflammatory process associated to experimental pleurisy in mice.
1/2012	Anti-inflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice.
10/2011	CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation.
8/2011	The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy.
3/2011	Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation.
4/2010	GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice.
2/2010	Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.
12/2009	PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore Cuzzocrea Research Topics

Disease

269	Inflammation (Inflammations) 03/2024 - 01/2002
71	Spinal Cord Injuries (Spinal Cord Injury) 03/2024 - 10/2004
69	Ischemia 03/2024 - 03/2002
61	Shock 03/2024 - 03/2002
61	Pain (Aches) 01/2024 - 06/2004
58	Reperfusion Injury 01/2024 - 01/2002
58	Edema (Dropsy) 07/2023 - 05/2002
43	Necrosis 07/2023 - 01/2002
42	Colitis 03/2024 - 07/2002
42	Neuroinflammatory Diseases 05/2023 - 01/2011
38	Body Weight (Weight, Body) 10/2022 - 10/2002
37	Lung Injury 03/2024 - 01/2002
34	Hyperalgesia 07/2023 - 06/2004
33	Pleurisy (Pleuritis) 01/2024 - 01/2002
33	Wounds and Injuries (Trauma) 01/2023 - 07/2002
32	Neoplasms (Cancer) 05/2023 - 06/2003
31	Myelitis 01/2014 - 02/2005
25	Pancreatitis 03/2024 - 05/2002
25	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2021 - 07/2002
22	Multiple Organ Failure (MODS) 03/2024 - 10/2002
22	Pneumonia (Pneumonitis) 06/2023 - 08/2003
21	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 03/2005
19	Arthritis (Polyarthritis) 01/2024 - 10/2002
19	Fibrosis (Cirrhosis) 07/2023 - 11/2006
18	Septic Shock (Toxic Shock Syndrome) 07/2011 - 11/2002
17	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 11/2012
16	Parkinson Disease (Parkinson's Disease) 04/2024 - 09/2010
15	Experimental Arthritis 10/2022 - 01/2002
15	Weight Loss (Weight Reduction) 10/2020 - 07/2002
13	Brain Injuries (Brain Injury) 06/2022 - 02/2011
12	Alzheimer Disease (Alzheimer's Disease) 07/2023 - 09/2010
12	Neuralgia (Stump Neuralgia) 11/2022 - 05/2012
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2023 - 02/2006
11	Hypoxia (Hypoxemia) 04/2023 - 09/2004
11	Hypersensitivity (Allergy) 11/2022 - 02/2006
11	Periodontitis 01/2018 - 06/2005
10	Endometriosis 03/2023 - 01/2016
10	Rheumatoid Arthritis 01/2023 - 01/2005
10	Acute Lung Injury 03/2022 - 07/2002

Drug/Important Bio-Agent (IBA)

79	CytokinesIBA 07/2023 - 06/2002
67	palmidrolIBA 03/2024 - 09/2007
64	CarrageenanIBA 01/2024 - 01/2002
62	3-nitrotyrosineIBA 01/2018 - 05/2002
59	Peroxidase (Myeloperoxidase)IBA 08/2021 - 02/2003
53	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 02/2003
42	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2002
42	AntioxidantsIBA 07/2023 - 02/2002
40	NF-kappa B (NF-kB)IBA 12/2023 - 01/2002
40	EnzymesIBA 07/2023 - 01/2002
39	LigandsIBA 01/2024 - 07/2002
35	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2024 - 01/2002
32	ZymosanIBA 03/2024 - 01/2002
32	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022 - 07/2002
32	Peroxynitrous Acid (Peroxynitrite)IBA 12/2014 - 02/2002
31	DinitrobenzenesIBA 03/2024 - 07/2002
31	2,4-dinitrofluorobenzene sulfonic acidIBA 03/2024 - 07/2002
29	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 02/2002
28	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2024 - 01/2002
28	Sulfonic AcidsIBA 03/2024 - 07/2002
27	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 01/2002
26	Transcription Factors (Transcription Factor)IBA 07/2023 - 01/2002
24	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021 - 01/2002
23	Bleomycin (Blenoxane)FDA LinkGeneric 06/2023 - 05/2005
23	Superoxides (Superoxide)IBA 04/2020 - 02/2002
23	PPAR alphaIBA 01/2010 - 07/2002
22	LipopolysaccharidesIBA 01/2022 - 03/2003
21	Superoxide DismutaseIBA 03/2020 - 06/2002
20	CeruletideIBA 03/2024 - 05/2002
18	Neuroprotective AgentsIBA 11/2020 - 02/2011
18	MelatoninIBA 12/2019 - 02/2002
17	Lipase (Acid Lipase)FDA Link 08/2020 - 05/2002
17	Amylases FDA Link 08/2020 - 05/2002
16	Analgesics (Analgesic Drugs)IBA 06/2023 - 11/2007
16	P-SelectinIBA 01/2021 - 01/2002
15	Interleukin-6 (Interleukin 6)IBA 03/2023 - 06/2002
15	Therapeutic UsesIBA 12/2022 - 05/2004
15	Interleukin-1beta (Interleukin 1 beta)IBA 08/2017 - 01/2002
14	InflammasomesIBA 03/2024 - 01/2017
14	LuteolinIBA 03/2024 - 01/2013
14	Collagen Type II (Type II Collagen)IBA 01/2024 - 10/2002
14	PPAR gammaIBA 02/2009 - 05/2002
13	CreatinineIBA 09/2022 - 08/2002
13	ProstaglandinsIBA 01/2018 - 05/2002
13	Poly Adenosine Diphosphate RiboseIBA 07/2011 - 08/2002
13	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2010 - 02/2005
12	CollagenIBA 07/2023 - 06/2005
12	Oxygen (Dioxygen)IBA 05/2023 - 02/2002
12	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 05/2002
12	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2002
11	Dexamethasone (Maxidex)FDA LinkGeneric 02/2023 - 06/2005
11	Malondialdehyde (Propanedial)IBA 01/2023 - 11/2002
11	Fatty Acids (Saturated Fatty Acids)IBA 03/2022 - 02/2008
11	AcidsIBA 04/2021 - 07/2002
11	GlucocorticoidsIBA 01/2012 - 11/2004
10	PolyphenolsIBA 07/2023 - 05/2005

Therapy/Procedure

70	Therapeutics 01/2024 - 01/2002
38	Laminectomy 01/2019 - 10/2004
25	Intraperitoneal Injections 01/2023 - 05/2002
14	Oral Administration 07/2023 - 08/2006
14	Drug Therapy (Chemotherapy) 11/2022 - 08/2006